News
4h
Barchart on MSNA $1.3 Billion Reason to Buy Eli Lilly Stock NowEli Lilly (LLY) is a pharmaceutical company that focuses on cardiometabolic health, neuroscience, oncology, and immunology.
The shipments have vaulted Ireland, a country of only five million people, into the second-largest goods-trade imbalance with the U.S., trailing only China.
Eli Lilly seems to have responded to the ... shortages, and reduced investment in R&D. Lilly's announcement comes just a few days after Lilly's chief executive, David Ricks, and other pharma ...
10h
Zacks Investment Research on MSNEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results